Connection
Matthew Greenhawt to Polyethylene Glycols
This is a "connection" page, showing publications Matthew Greenhawt has written about Polyethylene Glycols.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.407 |
|
|
|
-
Greenhawt M, Shaker M. Reply to "Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines". J Allergy Clin Immunol Pract. 2023 02; 11(2):666-667.
Score: 0.145
-
Rush C, Faulk KE, Bradley ZK, Turner A, Krumins M, Greenhawt M. The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience. J Allergy Clin Immunol Pract. 2022 02; 10(2):630-632.
Score: 0.133
-
Abrams EM, Greenhawt M, Shaker M, Kosowan L, Singer AG. Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada. Ann Allergy Asthma Immunol. 2021 10; 127(4):446-450.e1.
Score: 0.128